Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|September 27, 2021
HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector FunctionSimone I Richardson, Frances Ayres, Nelia P Manamela, et al.
Structure (London, England : 1993)|February 5, 2026
Defining the mechanism of cross-reactivity for a SARS-CoV-2 Beta-elicited antibody toward omicron sub-lineagesFrances Ayres, Bronwen Lambson, Nonhlanhla N Mkhize, et al.
Scientific Reports|June 10, 2024
Evaluating the antibody response elicited by diverse HIV envelope immunogens in the African green monkey (Vervet) modelThandeka Moyo-Gwete, Frances Ayres, Nonkululeko B Mzindle, et al.
Scientific Reports|October 1, 2022
Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanismsThandeka Moyo-Gwete, Cathrine Scheepers, Zanele Makhado, et al.
Iscience|July 31, 2025
SARS-CoV-2 vaccines elicit differential Fc effector functionsNelia P Manamela, Boitumelo M Motsoeneng, Holly Spencer, et al.
Frontiers in Immunology|August 21, 2023
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccinationBoitumelo M Motsoeneng, Nelia P Manamela, Haajira Kaldine, et al.
The Journal of Infection|January 18, 2026
Monitoring broadly neutralising HIV antibody concentrations using microsampling on dried blood spots in infantsRémi Latour, Nonhlanhla N Mkhize, Ségolène Debiesse, et al.
Scientific Reports|February 14, 2025
Population shift in antibody immunity following the emergence of a SARS-CoV-2 variant of concernJinal N Bhiman, Vimbai Sharon Madzorera, Qiniso Mkhize, et al.
Cell Reports. Medicine|March 2, 2022
SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivitySimone I Richardson, Nelia P Manamela, Boitumelo M Motsoeneng, et al.
BMC Medicine|November 19, 2021
SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021Jonathan Mandolo, Jacquline Msefula, Marc Y R Henrion, et al.
Pageof 3